Ribon Therapeutics Investors

19 investors on Angel Roster list Ribon Therapeutics in their portfolio. Most are venture capital firms and university program investors, the most common stage is Series A and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Ribon Therapeutics can appear together.

Investors listed
19
With verified email
58%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 19 Ribon Therapeutics investors

The most complete profiles first. Showing 19 of 19.

  • David GoeddelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Peter SvennilsonVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Jon RootVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Rick LewisVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Steve KrauszVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 66 more

    Verified email available

  • Jacques Benkoski

    Venture Capital, Strategy Operator, CEO · United States

    Series AHealth CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Tim Kutzkey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Dafina Toncheva

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • JJ Kang

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • James Evangelista

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Cameron WheelerVerified

    Venture Capital, Investment Partner, Investor · United States

    Series BHealth CareInformation Technology (IT)BiotechnologyConsumer Health

    Portfolio: Ribon Therapeutics, Neomorph, Blade Therapeutics, Pairwise Plants LLC

    Verified email available

Frequently asked questions

How many Ribon Therapeutics investors are on Angel Roster?

Angel Roster lists 19 Ribon Therapeutics investors. 11 of them (58%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), University Program Investors (8) and Private Equity Firms (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Ribon Therapeutics investors invest in?

Among those that list a stage, the most common are Series A (6), Seed (3) and Series B (1).

Where are Ribon Therapeutics investors based?

Most are based in the United States (19).

Which companies have Ribon Therapeutics investors backed?

The most-backed portfolio companies among them are Effector Therapeutics (18), Neuros Medical (13), Cleave Therapeutics (13), Escient Pharmaceuticals (13) and Blade Therapeutics (9).

How do I contact Ribon Therapeutics investors?

Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.